Skip to content

Insider · CIK 0001341642

David Henry Mack

ceopresidentofficerdirector

Files at PMVP (PMV Pharmaceuticals, Inc.). First filing Jul 3, 2025, latest Jul 3, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $62k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PMVP: PMV Pharmaceuticals, Inc.

PMVPOct 9, 2026 · close 1.52

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
47Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
$62k
58,411 shares
-10%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 27, 2025PMVP
PMV Pharmaceuticals, Inc.
MOption exercise
Common Stock
+220,643$1.37$302k451,109Oct 29, 2025
Oct 27, 2025PMVP
PMV Pharmaceuticals, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative
-220,643$0.00$00Oct 29, 2025
Jul 1, 2025PMVP
PMV Pharmaceuticals, Inc.
SOpen-market sale
Common Stock
-58,411$1.06$62k536,133Jul 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David Henry Mack: insider trades and track record | InsiderTell